December 4, 2017 / 7:53 AM / 7 days ago

BRIEF-BIOTON Closes Sale Of Tricel

Dec 4 (Reuters) - BIOTON SA:

* SAID ON SUNDAY THAT IT CLOSED TRANSACTION OF SELLING 100% STAKE OF ITS UNIT TRICEL TO MEDWISE PHARMACEUTICALS LIMITED BASED IN CANADA

* DEAL ALSO CONCERNED TRANSFER OF THE COMPANY‘S RECEIVABLES TO MEDWISE AND RETURN OF LOAN GRANTED TO TRICEL AND THE RETURN OF A LOAN GRANTED TO FISIOPHARMA, ITALIAN UNIT OF TRICEL

* COMPANY RECEIVED EUR 1.0 MILLION WHAT ENDED THE SALE PROCESS OF SHARES IN TRICEL AND THE TRANSFER OF FISIOPHARMA DEBTS TO MEDWISE

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below